Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

MPA increases cancer spread by boosting Eph A2 activity.

Young adults with hair loss face higher risk of stiff arteries.

OXI1 kinase is essential for plant defense and root hair growth in Arabidopsis.

AP-1 controls tumor cell type by affecting key signaling pathways.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Eclipta alba may improve memory and help treat Alzheimer's disease.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Alopecia areata patients have eye issues and need regular eye exams.

JAK inhibitors might help treat alopecia areata.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Apremilast did not work for treating severe alopecia areata.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Aortic aneurysm treatment has shifted to less invasive methods, improving safety and outcomes.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

'Eclipta prostrata' plants in Taiwan are infected with 'Candidatus Phytoplasma aurantifolia'.